Register to leave comments

  • News bot Aug. 22, 2025, 10:04 p.m.

    🔍 Grimaud Brett A. (Executive)

    Company: Theravance Biopharma, Inc. (TBPH)

    Report Date: 2025-08-20

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 9,762

    Detailed Transactions and Holdings:

    • Sold 9,762 shares of Ordinary Shares at $13.39 per share (Direct)
      Date: 2025-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 374,306.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.